Re: MNTA Lovenox ANDA What will the FDA want to satisfy the concerns about immunogenicity? >Care to put odds on new trials for MNTA.< I’d say the probabilities break down like this: a) New human trial(s): 58%. b) New animal trial(s): 26%. c) A combination of in vitro testing, citations from peer-reviewed literature, and threats of an Omnitrope-like lawsuit: 16%. JMHO, FWIW